This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Five Dumbest Things on Wall Street: Nov. 28

Pfizer Pulls Plug on Video Game

The Food & Drug Administration is prudishly taking the viva out of Pfizer's (PFE - Get Report) Viagra video game.

The pharmaceutical giant pulled the plug on Viva Cruiser, an "advergame" designed to promote the company's popular erectile dysfunction drug, according to the latest edition of international business Web magazine Multinational Monitor. The video game, which was running on earlier this month, was pulled shortly after the FDA pressured Pfizer to remove a video ad that was airing on without the required warning messages.

In the Viva Cruiser game, players guided a motorcyclist down a desert road picking up gifts for a date, including small, diamond-shaped blue pills (you know the ones). Viagra's "Viva Viagra" theme song played in the background with a narrator's voice saying, "Don't let erectile dysfunction get you down."

Don't they have bigger issues to worry about in Washington these days?

We at The Five Dumbest Lab believe that it was awfully limp of the FDA to neuter Pfizer's online-ad campaign.

Not that it matters to the FDA, but many other video games promote far more dangerous human interactions. Consider Take Two's (TTWO - Get Report) violent Grand Theft Auto or Midway's (MWY) Mortal Kombat.

The dumbest thing about all this is that the FDA has never published any online advertising regulations. Pfizer might not be pushing boundaries if they knew where they were drawn.

Dumb-o-meter score: 80 -- Bring back Viva Cruiser. Make love, not war games.

4 of 5

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
C $51.00 -0.37%
F $15.98 -0.19%
GM $37.31 -0.11%
NYT $13.41 1.21%
MSFT $40.97 -0.58%


DOW 17,712.66 +34.43 0.19%
S&P 500 2,061.02 +4.87 0.24%
NASDAQ 4,891.2190 +27.8570 0.57%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs